Pera Labs

Pera Labs, established in 2019 by Burak Özkösem, is a fertility technology company focused on addressing the high failure rates of fertility treatments. The company is headquartered in Philadelphia, USA, with a European base in Malta that serves as a center for RDI and EU regulatory affairs. Özkösem, who holds a Ph.D. and has a background as a researcher in reproductive health, founded the company to apply his expertise in areas like AI-based bioimaging and lab-on-a-chip technology to reproductive challenges.

The company's business is centered on developing and providing advanced solutions to fertility clinics. Pera Labs aims to reduce the financial and emotional burden on couples by improving the success rates of treatments like In Vitro Fertilization (IVF). The business model involves selling its specialized analysis devices to clinics and potentially offering services on a subscription basis for periodical fertility monitoring.

Pera Labs' flagship technology is the SPERMAN® system, an AI-powered device that automates sperm analysis and selection. This system utilizes a combination of microfluidic chip technology, deep-learning algorithms, and polarized optics to assess sperm quality at a single-cell level. It is designed to be significantly faster and more accurate than traditional methods, capable of analyzing sperm DNA quality non-invasively without harming the cells. In addition to the sperm analyzer, the company has also developed the HUGO device for cloud-based egg quality analysis and the FIMS device for monitoring a couple's reproductive health and pregnancy. The company also offers direct-to-consumer fertility and genetic tests, supplements, and counseling services through its online platform.

Keywords: fertility technology, reproductive health, AI sperm analysis, lab-on-a-chip, IVF solutions, sperm selection, Burak Özkösem, fertility clinics, reproductive medicine, microfluidics, SPERMAN, HUGO FIMS, non-invasive sperm DNA analysis, fertility treatments, digital health, male fertility, oocyte analysis, genetic testing, fertility monitoring, MedTech